XML 44 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Note 2 - Significant Accounting Policies (Details Textual)
$ in Thousands
1 Months Ended 4 Months Ended 9 Months Ended
Jun. 03, 2024
USD ($)
Feb. 01, 2024
USD ($)
Sep. 30, 2022
USD ($)
Dec. 23, 2021
Jul. 31, 2024
USD ($)
Feb. 29, 2024
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Number of Operating Segments               1  
Percentage of Royalty Receivable on Sale of Product Rights       30.00%          
Percentage Of Interest Earned on Outstanding Contract Royalty Asset       11.00%          
Payments of Debt Restructuring Costs               $ 21,179 $ (0)
The Credit and Guaranty Agreement [Member] | Initial Term Loan [Member]                  
Debt Instrument, Face Amount $ 67,100                
Conversion of 2026 Notes into New Term Loans [Member]                  
Debt Instrument, Unamortized Premium 29,800                
Debt Conversion, Original Debt, Amount 118,100                
Proceeds from Issuance of Debt 88,300                
Payments of Debt Restructuring Costs $ 21,200       $ 600   $ 21,200    
DRI Healthcare Acquisition LP [Member]                  
Proceeds From Royalty Obligation   $ 115,500 $ 125,000     $ 115,500      
Royalty Interest Rate   10.27%       10.27%